578 related articles for article (PubMed ID: 21961825)
1. The state of hormonal contraception today: benefits and risks of hormonal contraceptives: combined estrogen and progestin contraceptives.
Shulman LP
Am J Obstet Gynecol; 2011 Oct; 205(4 Suppl):S9-13. PubMed ID: 21961825
[TBL] [Abstract][Full Text] [Related]
2. The state of hormonal contraception today: benefits and risks of hormonal contraceptives: progestin-only contraceptives.
Burke AE
Am J Obstet Gynecol; 2011 Oct; 205(4 Suppl):S14-7. PubMed ID: 21961819
[TBL] [Abstract][Full Text] [Related]
3. Progestins for contraception: modern delivery systems and novel formulations.
Royer PA; Jones KP
Clin Obstet Gynecol; 2014 Dec; 57(4):644-58. PubMed ID: 25314087
[TBL] [Abstract][Full Text] [Related]
4. Hormonal contraception: noncontraceptive benefits and medical contraindications.
Rager KM; Omar HA
Adolesc Med Clin; 2005 Oct; 16(3):539-51. PubMed ID: 16183538
[TBL] [Abstract][Full Text] [Related]
5. [Current aspects of the oral hormonal contraception].
Avramova V
Akush Ginekol (Sofiia); 2008; 47 Suppl 2():49-59. PubMed ID: 19504710
[No Abstract] [Full Text] [Related]
6. [Diffuse symptoms in young women may indicate venous thromboembolism. Important to ask about the use of combined hormonal contraception].
Milsom I; von Sydow H; Thörn AB; Björkelund C; Odlind V
Lakartidningen; 2012 Sep 19-26; 109(38):1680-2. PubMed ID: 23094400
[No Abstract] [Full Text] [Related]
7. Venous thromboembolism in women taking hormonal contraceptives.
Blanco-Molina A; Monreal M
Expert Rev Cardiovasc Ther; 2010 Feb; 8(2):211-5. PubMed ID: 20136607
[TBL] [Abstract][Full Text] [Related]
8. Metabolic effects of contraceptive steroids.
Sitruk-Ware R; Nath A
Rev Endocr Metab Disord; 2011 Jun; 12(2):63-75. PubMed ID: 21538049
[TBL] [Abstract][Full Text] [Related]
9. Progestin-only contraception and venous thromboembolism.
Blanco-Molina MA; Lozano M; Cano A; Cristobal I; Pallardo LP; Lete I
Thromb Res; 2012 May; 129(5):e257-62. PubMed ID: 22425318
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in hormonal contraception.
Erkkola R
Curr Opin Obstet Gynecol; 2007 Dec; 19(6):547-53. PubMed ID: 18007132
[TBL] [Abstract][Full Text] [Related]
11. The adverse effects of hormonal therapy.
Bush TL
Cardiol Clin; 1986 Feb; 4(1):145-52. PubMed ID: 3518931
[TBL] [Abstract][Full Text] [Related]
12. Progestin and estrogen potency of combination oral contraceptives and endometrial cancer risk.
Maxwell GL; Schildkraut JM; Calingaert B; Risinger JI; Dainty L; Marchbanks PA; Berchuck A; Barrett JC; Rodriguez GC
Gynecol Oncol; 2006 Nov; 103(2):535-40. PubMed ID: 16740300
[TBL] [Abstract][Full Text] [Related]
13. Sex steroids and breast cancer prevention.
Spicer DV; Pike MC
J Natl Cancer Inst Monogr; 1994; (16):139-47. PubMed ID: 7999456
[TBL] [Abstract][Full Text] [Related]
14. The state of hormonal contraception today: established and emerging noncontraceptive health benefits.
Maguire K; Westhoff C
Am J Obstet Gynecol; 2011 Oct; 205(4 Suppl):S4-8. PubMed ID: 21961824
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamics of combined estrogen-progestin oral contraceptives: 2. effects on hemostasis.
Farris M; Bastianelli C; Rosato E; Brosens I; Benagiano G
Expert Rev Clin Pharmacol; 2017 Oct; 10(10):1129-1144. PubMed ID: 28712325
[TBL] [Abstract][Full Text] [Related]
16. Systemic hormonal contraception and risk of venous thromboembolism.
Heikinheimo O; Toffol E; Partonen T; But A; Latvala A; Haukka J
Acta Obstet Gynecol Scand; 2022 Aug; 101(8):846-855. PubMed ID: 35633036
[TBL] [Abstract][Full Text] [Related]
17. Association of venous thromboembolism with hormonal contraception and thrombophilic genotypes.
Bergendal A; Persson I; Odeberg J; Sundström A; Holmström M; Schulman S; Björgell O; Kieler H
Obstet Gynecol; 2014 Sep; 124(3):600-609. PubMed ID: 25162263
[TBL] [Abstract][Full Text] [Related]
18. [Peroral hormonal contraception and risk of venous thromboembolism].
Ludka O; Spinar J; Musil V; Pozdísek Z
Vnitr Lek; 2010 May; 56(5):370-5. PubMed ID: 20578585
[TBL] [Abstract][Full Text] [Related]
19. [Hormonal contraception using estroprogestins].
Grio R; Piacentino R; Cellura A; Caccuri D; Zaccheo F; Baccarini G; Marchino GL; Borgarino S; Fuda G
Minerva Ginecol; 1990 Mar; 42(3):49-53. PubMed ID: 2187166
[TBL] [Abstract][Full Text] [Related]
20. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
van Leeuwen FE
Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
